This study analyzed trends in opioid prescribing among Mohs surgeons from 2014 through 2022. The data showed a significant decline in opioid prescriptions over the study period, reflecting successful adoption of opioid-sparing postoperative pain management strategies within the Mohs surgery community.

Opioid prescribing by Mohs surgeons has decreased significantly since 2014, reflecting broader efforts to reduce unnecessary opioid use.

Non-opioid pain management strategies are effective for most Mohs surgery patients and should be the default postoperative approach.